You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

booster shot

Showing 26 - 50 of 1,407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial (RQ3013, Comirnaty)

Not yet recruiting
  • COVID-19
  • RQ3013
  • Comirnaty
  • (no location specified)
May 26, 2022

Coronary Artery Disease Trial (SIT LESS Booster)

Not yet recruiting
  • Coronary Artery Disease
  • SIT LESS Booster
  • (no location specified)
Sep 7, 2023

Fertility Trial in Barcelona (150µg CFA (Elonva®) at stimulation day (SD) 1 and 100µg CFA(Elonva®) at SD 5, 150µg CFA (Elonva®)

Not yet recruiting
  • Fertility
  • 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5
  • 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
  • Barcelona, Spain
    Hospital Universitario Quiron Dexeus
Nov 10, 2023

Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery Trial in Cairo

Recruiting
  • Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery
  • Cairo, Egypt
    Ainshams University
Aug 11, 2023

Health Behavior, Colorectal Cancer, Influenza Trial in New Orleans (Financial incentive for colorectal cancer screening,

Recruiting
  • Health Behavior
  • +6 more
  • Financial incentive for colorectal cancer screening
  • +2 more
  • New Orleans, Louisiana
    Tulane University School of Medicine
Nov 13, 2023

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

Anesthesia; Adverse Effect, Anesthesia, Local Trial in Bologna (subarachnoid block)

Completed
  • Anesthesia; Adverse Effect
  • Anesthesia, Local
  • subarachnoid block
  • Bologna, BO, Italy
    Istituto Ortopedico Rizzoli
May 11, 2023

Healthy Participants Trial (Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF)

Not yet recruiting
  • Healthy Participants
  • Combination [RSVpreF+BNTb162b2]
  • +4 more
  • (no location specified)
May 31, 2023

Arthroplasty, Replacement, Knee Trial (Ropivacaine, Normal saline)

Not yet recruiting
  • Arthroplasty, Replacement, Knee
  • (no location specified)
Sep 19, 2023

COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)

Active, not recruiting
  • COVID-19
  • NVX-CoV2373
  • SARS-CoV-2 rS antigen/Matrix-M Adjuvant
  • Austin, Texas
  • +4 more
May 16, 2023

Post Operative Pain, Anesthesia, Nerve Block Trial in Iowa City (Interscalene Catheter, Exparel Single Shot Interscalene Block)

Not yet recruiting
  • Post Operative Pain
  • +3 more
  • Interscalene Catheter
  • Exparel Single Shot Interscalene Block
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
May 19, 2023

COVID-19 Vaccines Safety Tracking (CoVaST)

Recruiting
  • Adverse Reaction to Vaccine
  • COVID19 Vaccine
  • BNT162b2
  • +9 more
  • Philadelphia, Pennsylvania
  • +13 more
Apr 5, 2022

PRP, Sexual Function Disturbances, Genitourinary Syndrome of Menopause Trial (Injection of platelet-rich plasma, Injection of

Not yet recruiting
  • PRP
  • +4 more
  • Injection of platelet-rich plasma
  • Injection of saline
  • (no location specified)
Aug 31, 2023

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

Healthy Trial in Buenos Aires (RSVpreF+qIRV, qIRV, RSVpreF)

Recruiting
  • Healthy
  • RSVpreF+qIRV
  • +3 more
  • Buenos Aires, Argentina
    Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Mar 27, 2023

Postoperative Pain Trial (Single shot adductor canal block, Continuous adductor canal block)

Not yet recruiting
  • Postoperative Pain
  • Single shot adductor canal block
  • Continuous adductor canal block
  • (no location specified)
Feb 3, 2023

Covid19 Trial in Netherlands (Vaccination once with Janssen vaccine (only priming), Vaccination with Janssen vaccine followed

Recruiting
  • Covid19
  • Vaccination once with Janssen vaccine (only priming)
  • +3 more
  • Amsterdam, Netherlands
  • +3 more
Jun 26, 2021

Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

Not yet recruiting
  • Safety of a Single Dose of COMVIGEN Vaccine
  • +5 more
  • Comvigen (Bivalent, ChulaCov19 BNA159.2)
  • BIVALENT Pfizer/BNT vaccine
  • Bangkok, Thailand
  • +1 more
Jun 29, 2023

Influenza Trial in Canada (aTIV Primer, QIV Primer, aTIV Booster)

Completed
  • Influenza
  • aTIV Primer
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 28, 2022

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

Booster Dose of Comirnaty in Children Ages 6 Months Though 4

Not yet recruiting
  • SARS-CoV-2
  • COVID-19
  • COMIRNATY intramuscular injection
  • Tokyo, Japan
    Pfizer Local Country
Nov 8, 2023

HIV, Drug Resistance, Drug Drug Interaction Trial in Switzerland (DOR/DTG/3TC)

Not yet recruiting
  • HIV
  • +2 more
  • Basel, Switzerland
  • +6 more
Sep 7, 2023

SARS-CoV-2 Infection Trial (PTX-COVID19-B, Comirnaty®)

Not yet recruiting
  • SARS-CoV-2 Infection
  • PTX-COVID19-B
  • Comirnaty®
  • (no location specified)
Sep 7, 2022

Peripheral Nerve Block, Anxiety, Preoperative Anxiety Trial in Philadelphia (Music, Midazolam)

Recruiting
  • Peripheral Nerve Block
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 3, 2022